Australia’s Inventia Life Science raises $25m Series B funding

Illustration. Photo by National Cancer Institute on Unsplash.

Inventia Life Science, a biomedical research company, has raised A$35 million ($25 million) in a Series B funding round, led by Blackbird Ventures, to market its cell culture platform globally and grow its team, the company said in a statement on Thursday.

The latest funding has brought the company’s total fundraising to A$45 million to date.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter